KRW 24450.0
(-2.4%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 132.57 Billion KRW | -7.76% |
2022 | 143.73 Billion KRW | 193.53% |
2021 | 48.96 Billion KRW | -35.9% |
2020 | 76.38 Billion KRW | 5.52% |
2019 | 72.39 Billion KRW | 3.04% |
2018 | 70.25 Billion KRW | 73.29% |
2017 | 40.54 Billion KRW | -0.66% |
2016 | 40.81 Billion KRW | -17.55% |
2015 | 49.49 Billion KRW | 36.48% |
2014 | 36.26 Billion KRW | -3.66% |
2013 | 37.64 Billion KRW | -12.55% |
2012 | 43.05 Billion KRW | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 122.64 Billion KRW | -2.45% |
2024 Q1 | 125.72 Billion KRW | -5.17% |
2023 Q1 | 139.71 Billion KRW | -2.8% |
2023 FY | 132.57 Billion KRW | -7.76% |
2023 Q2 | 138.49 Billion KRW | -0.87% |
2023 Q4 | 132.57 Billion KRW | -4.06% |
2023 Q3 | 138.18 Billion KRW | -0.23% |
2022 Q4 | 143.73 Billion KRW | 134.85% |
2022 Q3 | 61.2 Billion KRW | -8.49% |
2022 Q2 | 66.88 Billion KRW | 54.37% |
2022 Q1 | 43.32 Billion KRW | -11.52% |
2022 FY | 143.73 Billion KRW | 193.53% |
2021 FY | 48.96 Billion KRW | -35.9% |
2021 Q3 | 58.31 Billion KRW | 1.18% |
2021 Q2 | 57.63 Billion KRW | -14.5% |
2021 Q1 | 67.41 Billion KRW | -11.74% |
2021 Q4 | 48.96 Billion KRW | -16.03% |
2020 Q2 | 73.42 Billion KRW | 7.23% |
2020 Q1 | 68.47 Billion KRW | -5.41% |
2020 FY | 76.38 Billion KRW | 5.52% |
2020 Q4 | 76.38 Billion KRW | 20.51% |
2020 Q3 | 63.38 Billion KRW | -13.67% |
2019 Q1 | 64.73 Billion KRW | -7.86% |
2019 FY | 72.39 Billion KRW | 3.04% |
2019 Q4 | 72.39 Billion KRW | 20.51% |
2019 Q3 | 60.07 Billion KRW | -6.14% |
2019 Q2 | 64 Billion KRW | -1.13% |
2018 Q3 | 53.59 Billion KRW | 41.62% |
2018 Q2 | 37.84 Billion KRW | -1.82% |
2018 Q1 | 38.54 Billion KRW | -4.94% |
2018 FY | 70.25 Billion KRW | 73.29% |
2018 Q4 | 70.25 Billion KRW | 31.1% |
2017 FY | 40.54 Billion KRW | -0.66% |
2017 Q2 | 39.7 Billion KRW | -1.09% |
2017 Q4 | 40.54 Billion KRW | 3.36% |
2017 Q3 | 39.22 Billion KRW | -1.21% |
2017 Q1 | 40.14 Billion KRW | 40.34% |
2016 Q3 | 41.24 Billion KRW | 9.21% |
2016 FY | 40.81 Billion KRW | -17.55% |
2016 Q4 | 28.6 Billion KRW | -30.64% |
2016 Q2 | 37.76 Billion KRW | -22.76% |
2016 Q1 | 48.88 Billion KRW | -1.24% |
2015 Q3 | 40.49 Billion KRW | 5.45% |
2015 Q2 | 38.39 Billion KRW | 1.19% |
2015 Q1 | 37.94 Billion KRW | 4.63% |
2015 FY | 49.49 Billion KRW | 36.48% |
2015 Q4 | 49.49 Billion KRW | 22.25% |
2014 Q4 | 36.26 Billion KRW | -2.58% |
2014 Q3 | 37.22 Billion KRW | 0.14% |
2014 Q2 | 37.17 Billion KRW | -0.69% |
2014 Q1 | 37.43 Billion KRW | -0.56% |
2014 FY | 36.26 Billion KRW | -3.66% |
2013 Q4 | 37.64 Billion KRW | -8.31% |
2013 FY | 37.64 Billion KRW | -12.55% |
2013 Q3 | 41.05 Billion KRW | -1.5% |
2013 Q2 | 41.68 Billion KRW | -2.9% |
2013 Q1 | 42.92 Billion KRW | -0.28% |
2012 FY | 43.05 Billion KRW | 0.0% |
2012 Q4 | 43.05 Billion KRW | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
BCWORLD PHARM. Co., Ltd. | 184.11 Billion KRW | 27.99% |